Abstract
Increasing the number of intestinal L cells—an alternative to GLP-1 therapy in type 2 diabetes mellitus?
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Nature clinical practice. Endocrinology & metabolism
Paper Title
Journal
Date